Immunogenicity of a Virus-Like-Particle Vaccine Containing Multiple Antigenic Epitopes of Toxoplasma gondii Against Acute and Chronic Toxoplasmosis in Mice弓形虫多抗原表位病毒样颗粒疫苗对小鼠急性和慢性弓形虫病的免疫原性FRONTIERS IN IMMUNOLOGYIF5.92019-03-2936OAAI
Clinical characteristics and effective treatments of scrub typhus-associated hemophagocytic lymphohistiocytosis in childrenJOURNAL OF ADVANCED RESEARCHIF132019-01-018OAAI
Protection via a ROM4 DNA vaccine and peptide against Toxoplasma gondii in BALB/c miceBMC INFECTIOUS DISEASESIF32017-01-1128OAAI
Vaccination with toxofilin DNA in combination with an alummonophosphoryl lipid A mixed adjuvant induces significant protective immunity against Toxoplasma gondiiBMC INFECTIOUS DISEASESIF32017-01-0524OAAI
Galactose-based Thermosensitive Nanogels for Targeted Drug Delivery of lodoazomycin Arabinofuranoside (IAZA) for Theranostic Management of Hypoxic Hepatocellular CarcinomaBIOMACROMOLECULESIF5.42015-06-0350PREAI
Alpha-galactosylceramide enhances protective immunity induced by DNA vaccine of the SAG5D gene of Toxoplasma gondiiBMC INFECTIOUS DISEASESIF32014-12-2021OAAI
DNA prime and peptide boost immunization protocol encoding the Toxoplasma gondii GRA4 induces strong protective immunity in BALB/c miceBMC INFECTIOUS DISEASESIF32013-10-2342OAAI
Identification and characterization of Toxoplasma gondii aspartic protease 1 as a novel vaccine candidate against toxoplasmosisPARASITES & VECTORSIF3.52013-06-1436OAAI
Toxoplasma gondii cathepsin proteases are undeveloped prominent vaccine antigens against toxoplasmosisBMC INFECTIOUS DISEASESIF32013-05-0728OAAI
Radiosynthesis, in vitro cellular uptake and in vivo biodistribution of 3′-O-(3-benzenesulfonylfuroxan-4-yl)-5-[125I]iodo-2′-deoxyuridine, a nucleoside-based nitric oxide donorNUCLEAR MEDICINE AND BIOLOGYIF32005-08-013PREAI
Cytotoxicity and cellular uptake of pyrimidine nucleosides for imaging herpes simplex type-1 thymidine kinase (HSV-1 TK) expression in mammalian cellsNUCLEAR MEDICINE AND BIOLOGYIF32004-07-0124PREAI
Design and synthesis of 3′- and 5′-O-(3-benzenesulfonylfuroxan-4-yl)-2′-deoxyuridines:: Biological evaluation as hybrid nitric oxide donor-nucleoside anticancer agentsJOURNAL OF MEDICINAL CHEMISTRYIF6.82004-02-2462PREAI
Blockade of TGF-β action ameliorates renal dysfunction and histologic progression in anti-GBM nephritisKIDNEY INTERNATIONALIF12.62003-07-0146OAAI
Synthesis of 3′- and 5′-nitrooxy pyrimidine nucleoside nitrate esters:: Nitric oxide donor agents for evaluation as anticancer and antiviral agentsJOURNAL OF MEDICINAL CHEMISTRYIF6.82003-02-1252PREAI